Public-registry site landscape for NCT04053634, a Chronic Obstructive Pulmonary Disease study sponsored by AstraZeneca. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04053634 (registry record) |
| Sponsor | AstraZeneca |
| Condition(s) | Chronic Obstructive Pulmonary Disease |
| Phase | PHASE3 |
| Listed sites | 343 |
| Site countries | United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czechia |
Eichor generates a preliminary site-risk snapshot for NCT04053634 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →